Revisiting Estrogen: Efficacy and Safety for Postmenopausal Bone Health
The rapid decline in endogenous estrogen production that occurs during menopause is associated with significant bone loss and increased risk for fragility fracture. While hormone therapy (HT) is an effective means to re-establish endogenous estrogen levels and reduce the risk of future fracture, its...
Saved in:
Main Authors: | Sandra M. Sacco, Wendy E. Ward |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2010-01-01
|
Series: | Journal of Osteoporosis |
Online Access: | http://dx.doi.org/10.4061/2010/708931 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Relationship between Postmenopausal Estrogen Deficiency and Aneurysmal Subarachnoid Hemorrhage
by: Sadaharu Tabuchi
Published: (2015-01-01) -
The Significance of ST Depression in a Postmenopausal Woman on Estrogen Therapy during Regadenoson Myocardial SPECT Imaging
by: Nishaki Kiran Mehta, et al.
Published: (2015-01-01) -
Coronary Heart Disease in Postmenopausal Women with Type II Diabetes Mellitus and the Impact of Estrogen Replacement Therapy: A Narrative Review
by: Marouane Boukhris, et al.
Published: (2014-01-01) -
2020 Grand challenge revisited: removing silos, advancing research to improve overall health
by: Martha J. Somerman, et al.
Published: (2024-07-01) -
Fezolinetant’s efficacy and safety in treatment of vasomotor symptoms in postmenopausal women: a meta-analysis and GRADE evaluation of randomized controlled trials
by: Abdallah R. Allam, et al.
Published: (2025-01-01)